Company Biostage Inc Nasdaq
Equities
US41690A1060
Advanced Medical Equipment & Technology
End-of-day quote
Other stock markets
|
||
- USD | - |
Business Summary
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Longevity Products
100.0
%
| - | - | 0 | 100.0 % | - |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Asia
100.0
%
| - | - | 0 | 100.0 % | - |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Jun Li He
CEO | Chief Executive Officer | 49 | 21-08-31 |
David Green
CEO | Chief Executive Officer | 59 | 12-05-02 |
Hong Yu
PSD | President | 52 | 18-05-30 |
Director of Finance/CFO | 49 | 22-08-07 | |
Shun Fu Hu
COO | Chief Operating Officer | - | - |
William Fodor
CTO | Chief Tech/Sci/R&D Officer | 65 | 17-06-30 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
David Green
CEO | Chief Executive Officer | 59 | 12-05-02 |
Ronald Packard
BRD | Director/Board Member | 60 | 23-04-04 |
James Shmerling
BRD | Director/Board Member | 69 | 18-03-28 |
Ting Li
BRD | Director/Board Member | 47 | 18-11-06 |
Jun Li He
CEO | Chief Executive Officer | 49 | 21-08-31 |
Jason Jing Chen
BRD | Director/Board Member | 62 | 18-02-06 |
Herman Sanchez
BRD | Director/Board Member | 49 | 21-01-18 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 14,315,091 | 6,787,830 ( 47.42 %) | 0 | 47.42 % |
Company contact information
Harvard Apparatus Regenerative Technology, Inc.
84 October Hill Road Suite 11
01746, Holliston
+
http://www.biostage.comSector
Sales per Business
Sales per region
1st Jan change | Capi. | |
---|---|---|
+7.87% | 219B | |
+11.83% | 192B | |
+18.87% | 142B | |
+30.03% | 111B | |
+2.09% | 65.32B | |
+14.15% | 52.45B | |
+2.68% | 49.8B | |
+6.60% | 43.43B | |
+1.85% | 35.95B |
- Stock Market
- Equities
- HRGN Stock
- Stock
- Company Biostage Inc